← Back to Search

Behavioural Intervention

Alcohol's Impact on Men's Sexual Risk Behavior

N/A
Waitlist Available
Led By Kelly Davis, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Consumed alcohol at least 2 times per week in the past 30 days
Ages 21-30
Must not have
A medical condition and/or medications which contraindicate alcohol consumption
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial explores the link between drinking, sexual risk behavior, and sexual aggression in men. It investigates how emotions, alcohol, and stress impact men's decisions to engage in sexual risk behavior and how lab results compare to real-world behavior.

Who is the study for?
This trial is for single men aged 21-30 who have had unprotected sex with a woman at least once in the past year, drink alcohol twice a week, and have been sexually active recently. Men with alcohol problems or medical issues that make drinking unsafe can't participate.
What is being tested?
The study looks at how alcohol affects sexual risk behaviors and aggression in men when interacting with women. It tests if men's emotions and their partner's mood influence these behaviors under the effects of both alcoholic and non-alcoholic beverages.
What are the potential side effects?
Since this trial involves consumption of alcoholic beverages, potential side effects include typical reactions to alcohol such as impaired judgment, dizziness, nausea, or hangover symptoms depending on individual tolerance.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have drunk alcohol at least twice a week in the last month.
Select...
I am between 21 and 30 years old.
Select...
I am male.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot drink alcohol due to my health condition or medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean score of sexual risk intentions
Secondary study objectives
Sexual risk behavior

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Partner Negative Mood ManipulationExperimental Treatment1 Intervention
Participants receive an experimental manipulation describing negative emotions in a hypothetical sexual partner.
Group II: Alcoholic beverageExperimental Treatment1 Intervention
Participants will receive a dose of alcohol mixed in fruit juice designed to achieve a peak breath alcohol concentration of .08%.
Group III: Partner Positive Mood ManipulationActive Control1 Intervention
Participants receive an experimental manipulation describing positive emotions in a hypothetical sexual partner.
Group IV: Non-alcoholic beverageActive Control1 Intervention
Participants will receive a beverage that does not contain alcohol (fruit juice only).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcoholic Beverage
2006
Completed Phase 1
~310

Find a Location

Who is running the clinical trial?

Georgia State UniversityOTHER
65 Previous Clinical Trials
30,700 Total Patients Enrolled
2 Trials studying Sexual Assault
3,465 Patients Enrolled for Sexual Assault
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,765 Total Patients Enrolled
4 Trials studying Sexual Assault
533 Patients Enrolled for Sexual Assault
Arizona State UniversityLead Sponsor
303 Previous Clinical Trials
108,082 Total Patients Enrolled
2 Trials studying Sexual Assault
3,465 Patients Enrolled for Sexual Assault
Kelly Davis, PhDPrincipal InvestigatorArizona State University
1 Previous Clinical Trials
420 Total Patients Enrolled
~4 spots leftby Dec 2027